健帆生物：公司目前生产经营一切正常

Group 1 - The company, Jianfan Biological, stated that its production and operations are currently normal and there are no significant risks that should be disclosed but have not been [2] - The company's stock price fluctuations are influenced by various factors, including macroeconomic conditions, market environment, and industry cycles [2] - The company will continue to focus on the development of its core business in blood purification and strive to improve its operating performance to provide good returns to investors [2]